 Carmen Sucharov
Concepts (357)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 20 | 2023 | 600 | 5.270 |
Why?
| | Cardiomyopathy, Dilated | 18 | 2023 | 350 | 4.470 |
Why?
| | Myocytes, Cardiac | 17 | 2021 | 449 | 3.350 |
Why?
| | Myocardium | 12 | 2020 | 911 | 2.320 |
Why?
| | Heart Failure | 16 | 2023 | 1958 | 2.030 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 24 | 1.580 |
Why?
| | Gene Expression Regulation | 14 | 2018 | 2322 | 1.510 |
Why?
| | Ventricular Remodeling | 4 | 2021 | 224 | 1.310 |
Why?
| | Phosphodiesterase 3 Inhibitors | 3 | 2019 | 13 | 1.240 |
Why?
| | Heart Ventricles | 13 | 2021 | 723 | 1.240 |
Why?
| | Receptors, Adrenergic, beta | 4 | 2016 | 126 | 1.230 |
Why?
| | YY1 Transcription Factor | 6 | 2015 | 27 | 1.190 |
Why?
| | Phosphoric Diester Hydrolases | 3 | 2016 | 44 | 1.020 |
Why?
| | Histone Deacetylases | 5 | 2013 | 194 | 0.930 |
Why?
| | Phosphorylation | 9 | 2021 | 1558 | 0.920 |
Why?
| | Transcriptome | 5 | 2021 | 723 | 0.890 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2017 | 114 | 0.880 |
Why?
| | Serum | 3 | 2019 | 57 | 0.870 |
Why?
| | Calcium-Binding Proteins | 4 | 2021 | 205 | 0.860 |
Why?
| | RNA, Messenger | 10 | 2021 | 2550 | 0.830 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 121 | 0.780 |
Why?
| | Focal Adhesions | 1 | 2021 | 42 | 0.750 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 21 | 0.740 |
Why?
| | Amniotic Fluid | 1 | 2021 | 64 | 0.740 |
Why?
| | Heart Defects, Congenital | 4 | 2021 | 683 | 0.740 |
Why?
| | Extracellular Matrix | 2 | 2021 | 436 | 0.720 |
Why?
| | Cardiomegaly | 5 | 2015 | 158 | 0.690 |
Why?
| | Signal Transduction | 11 | 2023 | 4501 | 0.660 |
Why?
| | Biomarkers | 7 | 2022 | 3397 | 0.650 |
Why?
| | Rats | 15 | 2021 | 4913 | 0.650 |
Why?
| | Adenylyl Cyclases | 2 | 2016 | 83 | 0.640 |
Why?
| | Receptors, Adrenergic, beta-1 | 2 | 2011 | 45 | 0.630 |
Why?
| | Phosphodiesterase Inhibitors | 2 | 2016 | 82 | 0.620 |
Why?
| | Calcium | 2 | 2021 | 1089 | 0.610 |
Why?
| | Animals, Newborn | 8 | 2021 | 777 | 0.590 |
Why?
| | Cardiomyopathies | 1 | 2021 | 298 | 0.590 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 154 | 0.580 |
Why?
| | Protein Kinase C | 2 | 2011 | 271 | 0.570 |
Why?
| | Ventricular Function, Left | 3 | 2018 | 477 | 0.560 |
Why?
| | Child | 23 | 2022 | 18401 | 0.550 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2017 | 286 | 0.540 |
Why?
| | Specimen Handling | 1 | 2018 | 153 | 0.540 |
Why?
| | Plasma | 1 | 2018 | 181 | 0.530 |
Why?
| | Animals | 32 | 2023 | 31565 | 0.530 |
Why?
| | Bleomycin | 5 | 2020 | 228 | 0.510 |
Why?
| | Exosomes | 1 | 2017 | 92 | 0.510 |
Why?
| | Ventricular Myosins | 3 | 2005 | 33 | 0.510 |
Why?
| | Transcription Factors | 7 | 2016 | 1526 | 0.500 |
Why?
| | Humans | 53 | 2023 | 114045 | 0.490 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 801 | 0.490 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 314 | 0.480 |
Why?
| | Cells, Cultured | 14 | 2019 | 3861 | 0.480 |
Why?
| | Cyclic AMP | 5 | 2019 | 225 | 0.480 |
Why?
| | Child, Preschool | 16 | 2021 | 9114 | 0.480 |
Why?
| | Connexin 43 | 2 | 2012 | 23 | 0.480 |
Why?
| | Down-Regulation | 6 | 2021 | 594 | 0.470 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 9 | 0.440 |
Why?
| | Gene Expression | 7 | 2017 | 1417 | 0.440 |
Why?
| | Polymorphism, Genetic | 2 | 2019 | 610 | 0.430 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 305 | 0.430 |
Why?
| | Heart Transplantation | 4 | 2016 | 670 | 0.430 |
Why?
| | Heart | 4 | 2021 | 613 | 0.420 |
Why?
| | Female | 34 | 2021 | 59324 | 0.410 |
Why?
| | Myosin Heavy Chains | 4 | 2014 | 178 | 0.410 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2012 | 170 | 0.410 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 39 | 0.400 |
Why?
| | DNA-Binding Proteins | 5 | 2005 | 1311 | 0.390 |
Why?
| | Male | 34 | 2021 | 55396 | 0.390 |
Why?
| | Sex Characteristics | 3 | 2019 | 636 | 0.390 |
Why?
| | Adrenergic beta-1 Receptor Agonists | 1 | 2011 | 5 | 0.380 |
Why?
| | Recovery of Function | 1 | 2015 | 573 | 0.370 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2011 | 41 | 0.370 |
Why?
| | RNA | 1 | 2016 | 806 | 0.350 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 130 | 0.350 |
Why?
| | Heart Diseases | 1 | 2013 | 329 | 0.340 |
Why?
| | Gene Expression Profiling | 6 | 2021 | 1518 | 0.330 |
Why?
| | Myocardial Infarction | 2 | 2018 | 932 | 0.330 |
Why?
| | Isoproterenol | 3 | 2018 | 105 | 0.320 |
Why?
| | Milrinone | 2 | 2021 | 24 | 0.310 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 484 | 0.310 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2021 | 38 | 0.300 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 64 | 0.290 |
Why?
| | Myocardial Contraction | 3 | 2019 | 318 | 0.290 |
Why?
| | Cardiolipins | 2 | 2020 | 70 | 0.280 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 239 | 0.270 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 64 | 0.260 |
Why?
| | Lung Injury | 2 | 2018 | 192 | 0.260 |
Why?
| | Infant | 9 | 2020 | 7943 | 0.260 |
Why?
| | Rats, Sprague-Dawley | 3 | 2021 | 2182 | 0.260 |
Why?
| | Inflammation | 4 | 2020 | 2464 | 0.250 |
Why?
| | Case-Control Studies | 5 | 2021 | 3003 | 0.240 |
Why?
| | Antigens, Nuclear | 1 | 2004 | 19 | 0.240 |
Why?
| | Echocardiography | 2 | 2021 | 569 | 0.230 |
Why?
| | Mice | 11 | 2023 | 14843 | 0.230 |
Why?
| | Protein Kinases | 1 | 2006 | 304 | 0.230 |
Why?
| | Age Factors | 6 | 2018 | 2885 | 0.220 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2014 | 156 | 0.210 |
Why?
| | Sarcomeres | 1 | 2023 | 90 | 0.210 |
Why?
| | Adult | 10 | 2021 | 30375 | 0.200 |
Why?
| | Phenotype | 5 | 2023 | 2784 | 0.200 |
Why?
| | Endopeptidase K | 1 | 2021 | 14 | 0.190 |
Why?
| | Mutation | 4 | 2023 | 3338 | 0.190 |
Why?
| | Receptor, EphA2 | 2 | 2018 | 19 | 0.190 |
Why?
| | Ribonucleases | 1 | 2021 | 52 | 0.190 |
Why?
| | Light Coagulation | 1 | 2021 | 7 | 0.190 |
Why?
| | Mice, Transgenic | 3 | 2023 | 1947 | 0.190 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2013 | 742 | 0.190 |
Why?
| | Fetoscopy | 1 | 2021 | 28 | 0.190 |
Why?
| | Serum Response Factor | 1 | 2021 | 29 | 0.190 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3498 | 0.180 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 113 | 0.180 |
Why?
| | Biological Products | 1 | 2023 | 166 | 0.180 |
Why?
| | Drainage | 1 | 2021 | 145 | 0.180 |
Why?
| | Cluster Analysis | 1 | 2021 | 452 | 0.170 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 237 | 0.170 |
Why?
| | Extracellular Fluid | 1 | 2019 | 30 | 0.170 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 76 | 0.160 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 1726 | 0.160 |
Why?
| | Apoptosis | 2 | 2019 | 2349 | 0.160 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 10 | 0.160 |
Why?
| | Prognosis | 3 | 2018 | 3315 | 0.160 |
Why?
| | Chromosome Fragility | 1 | 1999 | 2 | 0.160 |
Why?
| | Natriuretic Peptide, Brain | 2 | 2012 | 94 | 0.160 |
Why?
| | Troponin I | 1 | 2019 | 68 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2021 | 590 | 0.160 |
Why?
| | Ephrin-A2 | 1 | 2018 | 3 | 0.160 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2021 | 388 | 0.160 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 388 | 0.160 |
Why?
| | Trinucleotide Repeats | 1 | 1999 | 24 | 0.160 |
Why?
| | Fever | 1 | 2020 | 280 | 0.160 |
Why?
| | Prospective Studies | 5 | 2022 | 6195 | 0.160 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2009 | 109 | 0.160 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 53 | 0.150 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 22 | 0.150 |
Why?
| | Mitochondria, Heart | 2 | 2020 | 72 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 1880 | 0.150 |
Why?
| | Adolescent | 7 | 2021 | 17800 | 0.150 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 88 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 115 | 0.150 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 527 | 0.150 |
Why?
| | Pilot Projects | 1 | 2022 | 1360 | 0.150 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 4680 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 924 | 0.150 |
Why?
| | Freezing | 1 | 2018 | 84 | 0.140 |
Why?
| | Middle Aged | 10 | 2018 | 26605 | 0.140 |
Why?
| | Critical Illness | 1 | 2022 | 640 | 0.140 |
Why?
| | Blotting, Western | 3 | 2016 | 1143 | 0.140 |
Why?
| | Myocarditis | 1 | 2018 | 93 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.140 |
Why?
| | Death, Sudden, Cardiac | 1 | 2018 | 160 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2020 | 268 | 0.140 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2016 | 11 | 0.140 |
Why?
| | Cell Size | 1 | 2017 | 79 | 0.140 |
Why?
| | Protein Binding | 4 | 2013 | 1888 | 0.140 |
Why?
| | Transcription, Genetic | 5 | 2013 | 1310 | 0.140 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 75 | 0.130 |
Why?
| | Renin-Angiotensin System | 1 | 2017 | 72 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 256 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 348 | 0.130 |
Why?
| | Cell Line | 2 | 2021 | 2629 | 0.130 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 121 | 0.130 |
Why?
| | Hot Temperature | 1 | 2018 | 301 | 0.130 |
Why?
| | Receptors, Nicotinic | 1 | 2018 | 273 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 282 | 0.130 |
Why?
| | Vascular Resistance | 1 | 2017 | 340 | 0.130 |
Why?
| | Up-Regulation | 2 | 2018 | 802 | 0.130 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 3 | 2005 | 18 | 0.130 |
Why?
| | Stem Cell Transplantation | 1 | 2017 | 148 | 0.130 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 167 | 0.130 |
Why?
| | Sympathetic Nervous System | 1 | 2017 | 171 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 1999 | 344 | 0.130 |
Why?
| | Collagen Type III | 1 | 2015 | 15 | 0.120 |
Why?
| | Transcriptional Activation | 2 | 2008 | 337 | 0.120 |
Why?
| | DNA Primers | 3 | 2011 | 508 | 0.120 |
Why?
| | Cohort Studies | 3 | 2022 | 4883 | 0.120 |
Why?
| | Nanoparticles | 1 | 2018 | 312 | 0.120 |
Why?
| | Electron Transport Complex IV | 1 | 1995 | 53 | 0.120 |
Why?
| | Heart Rate | 1 | 2018 | 710 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 182 | 0.120 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 1736 | 0.120 |
Why?
| | Antibiotics, Antineoplastic | 3 | 2020 | 110 | 0.120 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1995 | 104 | 0.120 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 145 | 0.120 |
Why?
| | Microfilament Proteins | 1 | 2015 | 125 | 0.110 |
Why?
| | Stroke Volume | 1 | 2017 | 513 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2537 | 0.110 |
Why?
| | Peptides | 1 | 2018 | 847 | 0.110 |
Why?
| | ROC Curve | 1 | 2015 | 441 | 0.110 |
Why?
| | Biopsy | 1 | 2017 | 1024 | 0.110 |
Why?
| | Young Adult | 2 | 2021 | 10444 | 0.110 |
Why?
| | Promoter Regions, Genetic | 3 | 2004 | 1131 | 0.110 |
Why?
| | Analysis of Variance | 2 | 2016 | 1218 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 787 | 0.100 |
Why?
| | Lung | 3 | 2019 | 3521 | 0.100 |
Why?
| | Atrial Natriuretic Factor | 2 | 2016 | 56 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2018 | 830 | 0.100 |
Why?
| | Nuclear Proteins | 1 | 2016 | 591 | 0.100 |
Why?
| | Fibrosis | 3 | 2019 | 452 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 1995 | 607 | 0.090 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2014 | 221 | 0.090 |
Why?
| | Glycine | 1 | 2011 | 152 | 0.090 |
Why?
| | Heart-Assist Devices | 1 | 2016 | 500 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 266 | 0.090 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 229 | 0.090 |
Why?
| | Arginine | 1 | 2011 | 236 | 0.090 |
Why?
| | Genotype | 2 | 2020 | 1757 | 0.090 |
Why?
| | Pregnancy | 1 | 2021 | 5499 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 863 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2011 | 771 | 0.080 |
Why?
| | Fibroblasts | 1 | 2013 | 834 | 0.080 |
Why?
| | Adenosine Monophosphate | 2 | 2021 | 49 | 0.080 |
Why?
| | Time Factors | 4 | 2018 | 6077 | 0.080 |
Why?
| | PPAR alpha | 1 | 2008 | 52 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 270 | 0.080 |
Why?
| | Heat-Shock Proteins | 1 | 2008 | 112 | 0.070 |
Why?
| | Heart Function Tests | 1 | 2008 | 60 | 0.070 |
Why?
| | Computational Biology | 1 | 2011 | 528 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 31 | 0.070 |
Why?
| | Genetic Markers | 2 | 2018 | 320 | 0.070 |
Why?
| | Aged | 6 | 2018 | 18969 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2006 | 7 | 0.070 |
Why?
| | Indole Alkaloids | 1 | 2006 | 9 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2013 | 2173 | 0.070 |
Why?
| | Protein Phosphatase 2 | 1 | 2006 | 30 | 0.070 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 371 | 0.060 |
Why?
| | Carbazoles | 1 | 2006 | 76 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2019 | 475 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 60 | 0.060 |
Why?
| | Cytoplasm | 1 | 2006 | 255 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 77 | 0.060 |
Why?
| | Adrenergic beta-Agonists | 1 | 2006 | 125 | 0.060 |
Why?
| | Acute Coronary Syndrome | 1 | 2008 | 254 | 0.060 |
Why?
| | Calcium Channels, L-Type | 1 | 2006 | 107 | 0.060 |
Why?
| | Ku Autoantigen | 1 | 2004 | 13 | 0.060 |
Why?
| | Protein Transport | 1 | 2006 | 391 | 0.060 |
Why?
| | 3' Untranslated Regions | 2 | 2016 | 129 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 796 | 0.060 |
Why?
| | Actins | 1 | 2006 | 376 | 0.060 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 35 | 0.050 |
Why?
| | Suppression, Genetic | 1 | 2003 | 23 | 0.050 |
Why?
| | Haplotypes | 2 | 2018 | 448 | 0.050 |
Why?
| | Mutagenesis | 1 | 2003 | 168 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2764 | 0.050 |
Why?
| | Gene Deletion | 1 | 2003 | 356 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 768 | 0.050 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 6 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 41 | 0.040 |
Why?
| | Disease Progression | 1 | 2007 | 2371 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 122 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2006 | 1696 | 0.040 |
Why?
| | Transfection | 2 | 2007 | 863 | 0.040 |
Why?
| | X Chromosome | 1 | 1999 | 47 | 0.040 |
Why?
| | Minisatellite Repeats | 1 | 1999 | 38 | 0.040 |
Why?
| | Brazil | 1 | 1999 | 89 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 182 | 0.040 |
Why?
| | Flecainide | 1 | 2018 | 7 | 0.040 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 1999 | 51 | 0.040 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 36 | 0.040 |
Why?
| | Fragile X Syndrome | 1 | 1999 | 65 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2018 | 136 | 0.040 |
Why?
| | Protective Factors | 1 | 2018 | 86 | 0.040 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 83 | 0.040 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2018 | 59 | 0.040 |
Why?
| | DNA | 1 | 2004 | 1350 | 0.040 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2018 | 106 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 271 | 0.040 |
Why?
| | Genetics, Population | 1 | 1999 | 187 | 0.040 |
Why?
| | Inflammasomes | 1 | 2018 | 115 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 16 | 0.030 |
Why?
| | Galectin 3 | 1 | 2016 | 18 | 0.030 |
Why?
| | Cell Cycle | 1 | 2019 | 541 | 0.030 |
Why?
| | Sampling Studies | 1 | 2016 | 92 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2018 | 339 | 0.030 |
Why?
| | Transcription Elongation, Genetic | 1 | 2016 | 20 | 0.030 |
Why?
| | Transcription Initiation Site | 1 | 2016 | 40 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 368 | 0.030 |
Why?
| | Acetylation | 1 | 2016 | 209 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 291 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 396 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2019 | 694 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2017 | 5038 | 0.030 |
Why?
| | Action Potentials | 1 | 2018 | 406 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1995 | 108 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 739 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 917 | 0.030 |
Why?
| | GA-Binding Protein Transcription Factor | 1 | 1995 | 5 | 0.030 |
Why?
| | 3T3 Cells | 1 | 1995 | 140 | 0.030 |
Why?
| | Exons | 1 | 1995 | 301 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1995 | 51 | 0.030 |
Why?
| | Tissue Donors | 1 | 2016 | 314 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1995 | 255 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2114 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1995 | 345 | 0.030 |
Why?
| | Plasmids | 1 | 1995 | 343 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 14 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 486 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2016 | 283 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 69 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 1995 | 2783 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2013 | 104 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 59 | 0.030 |
Why?
| | HeLa Cells | 1 | 1995 | 563 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 107 | 0.030 |
Why?
| | Hydrogels | 1 | 2019 | 573 | 0.030 |
Why?
| | Exercise | 1 | 2003 | 1642 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 191 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 425 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 170 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2013 | 368 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 549 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 213 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2016 | 965 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1690 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 2562 | 0.020 |
Why?
| | Binding Sites | 1 | 1995 | 1166 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1259 | 0.020 |
Why?
| | Cattle | 1 | 2013 | 918 | 0.020 |
Why?
| | Registries | 2 | 2008 | 1764 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2090 | 0.020 |
Why?
| | MADS Domain Proteins | 1 | 2009 | 5 | 0.020 |
Why?
| | Myogenic Regulatory Factors | 1 | 2009 | 49 | 0.020 |
Why?
| | MEF2 Transcription Factors | 1 | 2009 | 55 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2008 | 43 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2008 | 40 | 0.020 |
Why?
| | Genes | 1 | 2008 | 223 | 0.020 |
Why?
| | Homozygote | 1 | 2008 | 187 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 157 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 250 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2008 | 294 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1024 | 0.020 |
Why?
| | United States | 2 | 2018 | 12137 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 2958 | 0.020 |
Why?
| | Gene Frequency | 1 | 2008 | 476 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 24 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 337 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2007 | 93 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 552 | 0.020 |
Why?
| | Risk Factors | 1 | 2018 | 8614 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 393 | 0.020 |
Why?
| | Genetic Testing | 1 | 2007 | 381 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 499 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 744 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1228 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2247 | 0.010 |
Why?
| | Hospitalization | 1 | 2008 | 1762 | 0.010 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 1 | 1995 | 10 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1995 | 77 | 0.010 |
Why?
| | TATA Box | 1 | 1995 | 22 | 0.010 |
Why?
| | Deoxyribonuclease I | 1 | 1995 | 34 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1995 | 193 | 0.010 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1995 | 81 | 0.010 |
Why?
| | Genes, Reporter | 1 | 1995 | 256 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 9049 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 1995 | 210 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1995 | 845 | 0.010 |
Why?
| | Kidney | 1 | 1995 | 1182 | 0.000 |
Why?
|
|
Sucharov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|